Table 1. The effects of supplementation with 10 or 50 µg/ml of pOVGP1 during in vitro fertilization on embryo development (D0–D1) (three replicates).

Groups	N	Cleavage, n Mean ± S.E.M. (%)	Blastocyst Yield
			D7, n Mean ± S.E.M. (%)	D8, n Mean ± S.E.M. (%)	D9, n Mean ± S.E.M. (%)
Control	160	131 (82.45 ± 4.27)	29 (19.32 ± 3.41)	35 (22.69 ± 2.66)	39 (25.72 ± 4.05)
IVF 10	237	186 (77.89 ± 4.40)	34 (14.23 ± 0.73)	48 (19.93 ± 2.26)	62 (26.08 ± 0.99)
IVF 50	182	147 (81.62 ± 3.15)	18 (10.79 ± 3.35)	33 (19.34 ± 4.48)	42 (24.51 ± 5.13)

N = total number of presumptive zygotes placed in culture. One way ANOVA (P > 0.05).